Your session is about to expire
← Back to Search
Behavioural Intervention
Mobile Health Exercise Regimen for Heart Valve Disease (HOMERUNHITTER Trial)
N/A
Recruiting
Led By Brian R. Lindman, MD, MSc
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Treated with a transcatheter heart valve intervention (e.g., transcatheter aortic valve implantation [in the native valve or valve-in-valve], mitral transcatheter edge-to-edge repair, mitral valve-in-valve) of the aortic, mitral, or tricuspid valve done via transfemoral access
Be older than 18 years old
Must not have
Those who require a walker or who cannot get out of a chair/bed on their own and walk independently (use of a cane is acceptable)
Transcatheter heart valve intervention done via any route other than a transfemoral approach
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over the entire available follow-up period for randomized participants (minimum of 6 months, maximum approximately 24-30 months).
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a home-based cardiac rehab program delivered using an app & digital tools to help improve health outcomes in those undergoing transcatheter heart valve interventions.
Who is the study for?
This trial is for heart valve disease patients who've had a transcatheter heart valve intervention via the leg. They must be able to use an activity tracker, not planning on joining center-based rehab, and capable of using digital tools without physical or mental limitations that would interfere.
What is being tested?
The study tests a home-based cardiac rehab program delivered through an app and digital tools after heart valve surgery. Participants are randomly assigned to control, hands-off mobile health intervention, or interactive mobile health intervention for either 12 or 24 weeks.
What are the potential side effects?
Since this trial involves exercise and lifestyle changes rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue. The specifics will depend on individual health conditions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had a heart valve procedure without open surgery.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I can walk on my own but may use a cane.
Select...
I had a heart valve procedure not through the groin area.
Select...
I had a stroke during or right after my heart valve procedure.
Select...
I had a pacemaker placed either before or after my heart valve procedure but within 6 weeks.
Select...
I do not have any conditions like blindness or dementia that would stop me from completing study tasks.
Select...
I am planning to join a heart rehab program at a center.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ over the entire available follow-up period for randomized participants (minimum of 6 months, maximum approximately 24-30 months).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over the entire available follow-up period for randomized participants (minimum of 6 months, maximum approximately 24-30 months).
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Probability of the hierarchical clinical event composite
Secondary study objectives
5 meter gait speed
6 minute walk distance
All-cause death
+13 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: HBCR interactiveExperimental Treatment1 Intervention
Home-based cardiac rehabilitation with mobile application and periodic video calls with exercise physiologist + AHA Life's Essential 8 sheets.
Group II: HBCR hands-offExperimental Treatment1 Intervention
Home-based cardiac rehabilitation with mobile application + AHA Life's Essential 8 sheets.
Group III: ControlActive Control1 Intervention
Standard of care course for an individual not participating in center based cardiac rehabilitation. AHA Life's Essential 8 Fact Sheets are provided to promote healthy living.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesOTHER
1,401 Previous Clinical Trials
2,459,930 Total Patients Enrolled
Morristown Medical CenterOTHER
2 Previous Clinical Trials
440 Total Patients Enrolled
Vanderbilt University Medical CenterLead Sponsor
906 Previous Clinical Trials
934,194 Total Patients Enrolled
Piedmont HealthcareOTHER
22 Previous Clinical Trials
5,399 Total Patients Enrolled
Inova Fairfax HospitalOTHER
11 Previous Clinical Trials
7,463 Total Patients Enrolled
Chattanooga-Hamilton County Hospital AuthorityOTHER
3 Previous Clinical Trials
266 Total Patients Enrolled
Medical University of South CarolinaOTHER
979 Previous Clinical Trials
7,400,590 Total Patients Enrolled
Duke Clinical Research InstituteOTHER
67 Previous Clinical Trials
242,037 Total Patients Enrolled
University of MichiganOTHER
1,862 Previous Clinical Trials
6,440,998 Total Patients Enrolled
Pinnacle Health Cardiovascular InstituteNETWORK
2 Previous Clinical Trials
1,088 Total Patients Enrolled